The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global CRISPR & Cas9 Market Research Report 2024
Synopsis
CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.
The global CRISPR & Cas9 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CRISPR & Cas9 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CRISPR & Cas9 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CRISPR & Cas9 in Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CRISPR & Cas9 include Caribou Biosciences, Integrated DNA Technologies(IDT), CRISPR Therapeutics, Merck, Mirus Bio, Editas Medicine, Takara Bio, Thermo Fisher Scientific and Horizon Discovery Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CRISPR & Cas9, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR & Cas9.
Report Scope
The CRISPR & Cas9 market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPR & Cas9 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR & Cas9 companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Caribou Biosciences
Integrated DNA Technologies(IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
Segment by Type
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR & Cas9 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.
The global CRISPR & Cas9 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CRISPR & Cas9 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CRISPR & Cas9 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CRISPR & Cas9 in Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CRISPR & Cas9 include Caribou Biosciences, Integrated DNA Technologies(IDT), CRISPR Therapeutics, Merck, Mirus Bio, Editas Medicine, Takara Bio, Thermo Fisher Scientific and Horizon Discovery Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CRISPR & Cas9, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR & Cas9.
Report Scope
The CRISPR & Cas9 market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPR & Cas9 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR & Cas9 companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Caribou Biosciences
Integrated DNA Technologies(IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
Segment by Type
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR & Cas9 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR & Cas9 Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Genome Editing
1.2.3 Genetic Engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR & Cas9 Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR & Cas9 Market Perspective (2019-2030)
2.2 CRISPR & Cas9 Growth Trends by Region
2.2.1 Global CRISPR & Cas9 Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CRISPR & Cas9 Historic Market Size by Region (2019-2024)
2.2.3 CRISPR & Cas9 Forecasted Market Size by Region (2025-2030)
2.3 CRISPR & Cas9 Market Dynamics
2.3.1 CRISPR & Cas9 Industry Trends
2.3.2 CRISPR & Cas9 Market Drivers
2.3.3 CRISPR & Cas9 Market Challenges
2.3.4 CRISPR & Cas9 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR & Cas9 Players by Revenue
3.1.1 Global Top CRISPR & Cas9 Players by Revenue (2019-2024)
3.1.2 Global CRISPR & Cas9 Revenue Market Share by Players (2019-2024)
3.2 Global CRISPR & Cas9 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRISPR & Cas9 Revenue
3.4 Global CRISPR & Cas9 Market Concentration Ratio
3.4.1 Global CRISPR & Cas9 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR & Cas9 Revenue in 2023
3.5 CRISPR & Cas9 Key Players Head office and Area Served
3.6 Key Players CRISPR & Cas9 Product Solution and Service
3.7 Date of Enter into CRISPR & Cas9 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR & Cas9 Breakdown Data by Type
4.1 Global CRISPR & Cas9 Historic Market Size by Type (2019-2024)
4.2 Global CRISPR & Cas9 Forecasted Market Size by Type (2025-2030)
5 CRISPR & Cas9 Breakdown Data by Application
5.1 Global CRISPR & Cas9 Historic Market Size by Application (2019-2024)
5.2 Global CRISPR & Cas9 Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CRISPR & Cas9 Market Size (2019-2030)
6.2 North America CRISPR & Cas9 Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CRISPR & Cas9 Market Size by Country (2019-2024)
6.4 North America CRISPR & Cas9 Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR & Cas9 Market Size (2019-2030)
7.2 Europe CRISPR & Cas9 Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CRISPR & Cas9 Market Size by Country (2019-2024)
7.4 Europe CRISPR & Cas9 Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR & Cas9 Market Size (2019-2030)
8.2 Asia-Pacific CRISPR & Cas9 Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CRISPR & Cas9 Market Size by Region (2019-2024)
8.4 Asia-Pacific CRISPR & Cas9 Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR & Cas9 Market Size (2019-2030)
9.2 Latin America CRISPR & Cas9 Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CRISPR & Cas9 Market Size by Country (2019-2024)
9.4 Latin America CRISPR & Cas9 Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR & Cas9 Market Size (2019-2030)
10.2 Middle East & Africa CRISPR & Cas9 Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CRISPR & Cas9 Market Size by Country (2019-2024)
10.4 Middle East & Africa CRISPR & Cas9 Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Caribou Biosciences
11.1.1 Caribou Biosciences Company Detail
11.1.2 Caribou Biosciences Business Overview
11.1.3 Caribou Biosciences CRISPR & Cas9 Introduction
11.1.4 Caribou Biosciences Revenue in CRISPR & Cas9 Business (2019-2024)
11.1.5 Caribou Biosciences Recent Development
11.2 Integrated DNA Technologies(IDT)
11.2.1 Integrated DNA Technologies(IDT) Company Detail
11.2.2 Integrated DNA Technologies(IDT) Business Overview
11.2.3 Integrated DNA Technologies(IDT) CRISPR & Cas9 Introduction
11.2.4 Integrated DNA Technologies(IDT) Revenue in CRISPR & Cas9 Business (2019-2024)
11.2.5 Integrated DNA Technologies(IDT) Recent Development
11.3 CRISPR Therapeutics
11.3.1 CRISPR Therapeutics Company Detail
11.3.2 CRISPR Therapeutics Business Overview
11.3.3 CRISPR Therapeutics CRISPR & Cas9 Introduction
11.3.4 CRISPR Therapeutics Revenue in CRISPR & Cas9 Business (2019-2024)
11.3.5 CRISPR Therapeutics Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck CRISPR & Cas9 Introduction
11.4.4 Merck Revenue in CRISPR & Cas9 Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Mirus Bio
11.5.1 Mirus Bio Company Detail
11.5.2 Mirus Bio Business Overview
11.5.3 Mirus Bio CRISPR & Cas9 Introduction
11.5.4 Mirus Bio Revenue in CRISPR & Cas9 Business (2019-2024)
11.5.5 Mirus Bio Recent Development
11.6 Editas Medicine
11.6.1 Editas Medicine Company Detail
11.6.2 Editas Medicine Business Overview
11.6.3 Editas Medicine CRISPR & Cas9 Introduction
11.6.4 Editas Medicine Revenue in CRISPR & Cas9 Business (2019-2024)
11.6.5 Editas Medicine Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Detail
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio CRISPR & Cas9 Introduction
11.7.4 Takara Bio Revenue in CRISPR & Cas9 Business (2019-2024)
11.7.5 Takara Bio Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific CRISPR & Cas9 Introduction
11.8.4 Thermo Fisher Scientific Revenue in CRISPR & Cas9 Business (2019-2024)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Detail
11.9.2 Horizon Discovery Group Business Overview
11.9.3 Horizon Discovery Group CRISPR & Cas9 Introduction
11.9.4 Horizon Discovery Group Revenue in CRISPR & Cas9 Business (2019-2024)
11.9.5 Horizon Discovery Group Recent Development
11.10 Intellia Therapeutics
11.10.1 Intellia Therapeutics Company Detail
11.10.2 Intellia Therapeutics Business Overview
11.10.3 Intellia Therapeutics CRISPR & Cas9 Introduction
11.10.4 Intellia Therapeutics Revenue in CRISPR & Cas9 Business (2019-2024)
11.10.5 Intellia Therapeutics Recent Development
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Detail
11.11.2 Agilent Technologies Business Overview
11.11.3 Agilent Technologies CRISPR & Cas9 Introduction
11.11.4 Agilent Technologies Revenue in CRISPR & Cas9 Business (2019-2024)
11.11.5 Agilent Technologies Recent Development
11.12 Cellecta
11.12.1 Cellecta Company Detail
11.12.2 Cellecta Business Overview
11.12.3 Cellecta CRISPR & Cas9 Introduction
11.12.4 Cellecta Revenue in CRISPR & Cas9 Business (2019-2024)
11.12.5 Cellecta Recent Development
11.13 GenScript
11.13.1 GenScript Company Detail
11.13.2 GenScript Business Overview
11.13.3 GenScript CRISPR & Cas9 Introduction
11.13.4 GenScript Revenue in CRISPR & Cas9 Business (2019-2024)
11.13.5 GenScript Recent Development
11.14 GeneCopoeia
11.14.1 GeneCopoeia Company Detail
11.14.2 GeneCopoeia Business Overview
11.14.3 GeneCopoeia CRISPR & Cas9 Introduction
11.14.4 GeneCopoeia Revenue in CRISPR & Cas9 Business (2019-2024)
11.14.5 GeneCopoeia Recent Development
11.15 Synthego
11.15.1 Synthego Company Detail
11.15.2 Synthego Business Overview
11.15.3 Synthego CRISPR & Cas9 Introduction
11.15.4 Synthego Revenue in CRISPR & Cas9 Business (2019-2024)
11.15.5 Synthego Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
